Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MARCKS like 1 pseudogene 2 (MARCKSL1P2) is annotated as a pseudogene related to the protein-coding gene MARCKS-like protein 1 (MARCKSL1). Pseudogenes are segments of DNA that resemble functional genes but are generally non-coding and non-functional due to mutations or disruptions in their sequence. There is no evidence that MARCKSL1P2 encodes a functional protein or acts as a therapeutic target. Research and disease associations are attributable to the protein-coding MARCKSL1 gene, not to MARCKSL1P2. If the intent is to refer to a functional signaling or structural protein involved in neurodevelopment, regeneration, or cytoskeletal regulation, the correct target is MARCKS-like protein 1 (MARCKSL1), not MARCKSL1P2. This pseudogene is not a current therapeutic or pharmacological target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MARCKS like 1 pseudogene 2 (MARCKSL1P2).